Smith Robert Paul JR 4

What Happened

• Robert Paul Smith Jr., Chief Commercial Officer of Gossamer Bio (GOSS), had two sets of stock options cancelled and immediately regranted as part of a one-time option repricing. The transactions on 2026-03-19 show dispositions of 562,500 and 572,000 previously outstanding options and corresponding acquisitions/grants of the same amounts — a total of 1,134,500 options.
• The repriced options now carry a reduced per-share exercise price of $0.45. The filing reports these as derivative transactions (options), not open-market stock sales or purchases, and no cash proceeds or share sales are reported.

Key Details

• Transaction date: March 19, 2026. Effective as of the "Repricing Date" March 19, 2026 (Footnote F1).
• Options cancelled and reissued: 562,500 and 572,000 (total 1,134,500) under the 2019 Incentive Award Plan.
• New exercise price: $0.45 per share for the repriced options (Footnote F1).
• Vesting/term: All other terms, including vesting and term, remain as previously set; grants vest per the original award agreements and require continued service (Footnote F2).
• Shares/units owned after transaction: not specified in the reported data.
• Filing timeliness: report covers activity on 2026-03-19 and was filed 2026-03-20; no late filing is indicated.

Context

• This is a repricing (replacement of outstanding options) rather than a purchase or sale of common stock. It reduces the strike price of existing options, potentially making them more valuable if the stock rises above $0.45.
• The repriced awards remain subject to their original vesting schedule and continued employment; this is not an immediate cashless exercise or sale of shares.